摘要
Transforming growth factor β (TGFβ) and hepatocyte growth factor (HGF) promote glioma progression. Using U87human astrocytoma cells, which express TGFβ receptors (TβRs), we show (1) mRNA expression of Smads (2, 3, 4), bone morphogenetic protein (BMP)- and activin-A receptors; (2) TGFβ1 inhibits and HGF induces proliferation; (3) TGFβ1 and activin-A equipotently inhibit HGF secretion more than BMP-2, but none alters c-Met expression. Because interfering with TβR signaling might nullify the beneficial inhibition of HGF secretion, activin-A should instead be considered for combination glioma therapy.